Skip to content

Search for:

New to Type 1 Diabetes

Living with Diabetes

Conferences & Community

News

About CWD

New to Type 1 Diabetes
Living with Diabetes
Conferences & Community
CWD Answers
News
About CWD
Donate to CWD
Search for:

Archives

Research News

advertisement

February 10, 2010

Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. See also Early Artificial Pancreas Trials Show Benefits for Kids, Teenagers with Diabetes While Sleeping Overnight and Insulin Study Could Lead to New Dosage Devices.
Space-time clustering analyses of type 1 diabetes in children from north-east England: support for an infectious aetiology?
PSECMAC Intelligent Insulin Schedule for Diabetic Blood Glucose Management Under Nonmeal Announcement.
High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice. See also Researchers Discover Protein that Triggers Islet Cell Rejection.

February 3, 2010

A simulation study of an inverse controller for closed- and semiclosed-loop control in type 1 diabetes.
Polysaccharide Multilayer Nanoencapsulation of Insulin-Producing beta-Cells Grown as Pseudoislets for Potential Cellular Delivery of Insulin.

January 27, 2010

Glucose Levels at the Site of Subcutaneous Insulin Administration and Their Relationship to Plasma Levels.
Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes.
Teplizumab therapy for type 1 diabetes.
Aluminum Gallium Nitride (GaN)/GaN High Electron Mobility Transistor-Based Sensors for Glucose Detection in Exhaled Breath Condensate. See also Breath-based glucose sensor developed (and why it may never make it to market).

January 20, 2010

Neuropsychological profiles of young people with type 1 diabetes 12 yr after disease onset.
High caloric and sodium intakes as risk factors for progression of retinopathy in type 1 diabetes mellitus.
Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: Findings from the Coronary Artery Calcification in Type 1 Diabetes study.
Coronary vasoreactivity is not altered in young people with type 1 diabetes.
Automated detection of hypoglycemia-induced EEG changes recorded by subcutaneous electrodes in subjects with type 1 diabetes-The brain as a biosensor.
Immunity to poliovirus after vaccination of children with type 1 diabetes mellitus and rheumatic diseases.

January 13, 2010

Dimorphic histopathology of long-standing childhood-onset diabetes.
Circulating endothelial cells are elevated in patients with type 1 diabetes mellitus.
Birthweight and the risk of childhood-onset type 1 diabetes: a meta-analysis of observational studies using individual patient data.
Association between serum levels of the soluble receptor (sRAGE) for advanced glycation endproducts (AGEs) and their receptor (RAGE) in peripheral blood mononuclear cells of children with type 1 diabetes mellitus.
Helminthic therapy: using worms to treat immune-mediated disease.
Hypoglycemia unawareness in patients with type 1 diabetes: pilot study of naltrexone therapy.

January 6, 2010

Results of ITN insulin B-chain study for type 1 diabetes published summarizes Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy, previously reported.
Anti-inflammatory properties of C-Peptide.
C-Peptide: the missing link in diabetic nephropathy?
The beneficial effects of C-Peptide on diabetic polyneuropathy.
C-Peptide and its intracellular signaling.
A Molecular Level Understanding of Zinc Activation of C-peptide and its Effects on Cellular Communication in the Bloodstream.
Molecular effects of C-Peptide in microvascular blood flow regulation.
C-Peptide in the vessel wall.
Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-Peptide.
Pancreatic acellular matrix supports islet survival and function in a synthetic tubular device: in vitro and in vivo studies.
The in vivo performance of bioartificial pancreas in bone marrow cavity: A case report of a spontaneous diabetic feline.
Skeletal Muscle Metabolism in the Pathology and Treatment of Type 1 Diabetes.
Cardiovascular autonomic neuropathy, HDL-cholesterol, and smoking correlate with arterial stiffness markers determined 18 years later in type 1 diabetes.
Ductal Origin Hypothesis of Pancreatic Regeneration under Attack. Free full text available in PDF format.
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene. Free full text available in HTML and PDF formats. See also Leptin-Linked Gene Reverses [Type 2] Diabetes in Mice.

December 30, 2009

Use of the Site of Subcutaneous Insulin Administration for the Measurement of Glucose in Patients with Type 1 Diabetes.
No evidence of porcine endogenous retrovirus in patients with type 1 diabetes after long-term porcine islet xenotransplantation.
Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges with Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 Participants Running Title: C-peptide with Progression to Type 1 Diabetes.
Immunomodulation with heat shock protein DiaPep277 to preserve beta cell function in type 1 diabetes – an update.
Prevalence of Type 1 Diabetes auto-antibodies (GADA, IA2, IAA) in overweight and obese children.

December 23, 2009

Researchers Re-Defining the Concept of a Cure for Diabetes.
Six months of diazoxide treatment at bedtime in newly diagnosed subjects with type 1 diabetes does not influence parameters of beta-cell function and autoimmunity, but improves glycemic control.
Ethnic Differences in Incidence of Type 1 Diabetes among Second-Generation Immigrants and Adoptees from Abroad.
Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset.
Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice.
Association between serum levels of the soluble receptor (sRAGE) for advanced glycation endproducts (AGEs) and their receptor (RAGE) in peripheral blood mononuclear cells of children with type 1 diabetes mellitus.
Can Roux-en-Y gastric bypass provide a lifelong solution for diabetes mellitus? Free full text available in PDF format.

December 16, 2009

Population density determines the direction of the association between ambient ultraviolet radiation and type 1 diabetes incidence.
The Geoepidemiology of Type 1 Diabetes.
Tea, Coffee Seem to Protect Against [Type 2] Diabetes.
Age at the Introduction of Solid Foods During the First Year and Allergic Sensitization at Age 5 Years.

December 9, 2009

Researchers stop diabetes progression in a clinical trial discusses Rituximab, B-lymphocyte depletion, and preservation of beta-cell function, previously presented.
Real-time detection of nocturnal hypoglycemic episodes using a novel non-invasive hypoglycemia monitor.
Familial type 1 diabetes mellitus-gender distribution and age at onset of diabetes distinguish between parent-offspring and sib-pair subgroups.
Bone mass and sex steroids in postmenarcheal adolescents and adult women with Type 1 diabetes mellitus.

« Previous
1
…
66
67
68
69
70
…
94
Next »

advertisement

Last Updated: Wednesday, June 18, 2025 02:32:36 UTC

This internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

Terms of Use

About Us

Contact Us
- Contact Us
- Submit a Question

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes, EIN #46-3704802), a 501c3 not-for-profit organization, which is responsible for its contents. By using this site, you agree to our Terms of Use, Legal Notice and Privacy Policy.

Children with Diabetes.com © 1995-2025 | Comments and Feedback | All Rights Reserved.

Social

Four-Star Rating Badge - Full Color

DK Popup

This is a popup.

Submit Your Story

If you’d like your story to be considered for inclusion on our website, please fill out the form below.

Name*
First Last
Email*
Enter Email Confirm Email
Address
State / Province / Region Country

Please let us know about where you live.
Date of Birth*
Month
Day
Year
We ask for your birth date so that we can limit what is used on the website if you are under 18.
Date Diagnosed
Month
Day
Year
If you don't know the exact day, don't worry. Just choose the correct month and/or correct year and note this in your story.
Your Story*
Please tell us about yourself and your connection to diabetes.
Your Photo
Accepted file types: jpg, jpeg, png, Max. file size: 25 MB.
If you have a photo, upload it here.
Short Bio
Please include a short bio of yourself so we can consider it for inclusion with the story. This will appear underneath your photo.
Consent to Use My Story and Photo*
I agree with terms below.
By submitting my information, photo, and/or video, I give Children with Diabetes permission to use my story, imagery, photograph(s), and/or video(s), in its promotional materials and publicity efforts. I understand that the imagery may be used in, but not limited to, a publication, print ad, direct-mail piece, electronic media, or other form or promotion; and that my name and additional information collected by the organization may be used in conjunction with the image(s). I release Children with Diabetes from liability for any violation of any personal or proprietary right I may have in connection with such use.

Contact Us

Help Us Understand You Better.

Please answer a few questions to help us understand how best to serve you. You are not required to answer, but we hope you will. This information will be collated and may be published on our website periodically, or may be used for publication, but we will use composite data only. We do not maintain any individual data from these items. If you ask another question at a later time, please fill this out each time.

This form is just for questions related to diabetes care. If you have questions about anything else related to Children with Diabetes, please use our Contact Us form.
This question is on behalf of:
The question applies to this age group:
This question relates to:
We've had diabetes for:
We use this treatment for diabetes:
We have the following insurance:
We receive diabetes care from:
I'm asking this question because:
Type in Your Question Here.
What is your email address?
If you would like to have the answer emailed to you, please include your email address.
Where do you live?
Please tell us where you live (city, state, and country). This information can help us answer your question.
What is your question?*
To preserve confidentiality, we strongly recommend that you do not include in your question any information that identifies you, your child, or any other individual. Please note: questions that are published may be edited for space and clarity.
Comments
This field is for validation purposes and should be left unchanged.

First Name*
Last Name*
Email*
What is your connection to type 1 diabetes?*
- I have type 1 diabetes
- I have a child with type 1 diabetes
- I have type 1 and have a child with type 1
- I am a health care professional
- Other
Phone
This field is for validation purposes and should be left unchanged.